CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
Innovative tool for Cognitive Behavioural Therapy (CBT) in supportive care
Checkpoint blockers for skin cancer - effects in the periphery vs the central sites
The risks of combining therapies in renal cell carcinoma and bladder cancer
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma